You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
復星醫藥(02196.HK)與控股股東向病理人工智能軟件商杏脈科技增資
阿思達克 01-25 09:54
復星醫藥(02196.HK)公布,其全資附屬復星醫藥產業,與公司控股股東復星高科技之附屬亞東智健及寧波復脈,向目標公司杏脈科技分別增資9,000萬、2.1億及3,750萬元人民幣。完成後,公司透過復星醫藥產業及佛山禪醫將合共持有目標公司的股權由30%攤薄約28.24%。 杏脈科技為一間專注於研發、生產、銷售醫療影像及病理人工智能軟件及數字化解決方案的科創型企業,部分產品於2021年開始進入商業化,目前仍處於投入期。 公司指出,本次增資旨在解決目標公司現階段研發投入、市場推廣及日常運營的資金需求,將復星醫藥產業、亞東智健截至本次增資前對目標公司享有的存續債權轉換為資本出資,以及進一步加強對目標公司員工的激勵。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account